Largest pharmaceutical companies in the United States by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 44 pharmaceutical companies in the United States ranked by total assets, at CHF 175.3B, ahead of Johnson & Johnson (CHF 167.8B) and Merck & Co (CHF 115.3B). Figures as of 20 Nov 2026, 05:22 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- PfizerCHF 175.3B
- Median
- CHF 1.3B
- Combined market value
- CHF 3.15T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | CHF 175.3B | CHF 132.2B | CHF 23.19 | 1.85% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | CHF 167.8B | CHF 541.6B | CHF 224.97 | 2.04% down | 34% up | ||
| 3 | Merck & CoMRK · Health Care | CHF 115.3B | CHF 275.7B | CHF 111.84 | 3.61% down | 45% up | ||
| 4 | AbbVieABBV · Health Care | CHF 112.8B | CHF 422.1B | CHF 238.78 | 0.86% down | 25% up | ||
| 5 | Eli LillyLLY · Health Care | CHF 94.7B | CHF 1.01T | CHF 1,137.83 | 2.29% down | 33% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | CHF 75.8B | CHF 100.4B | CHF 49.13 | 2.05% down | 30% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | CHF 73B | CHF 151.5B | CHF 87.47 | 0.58% down | 16% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | CHF 34.2B | CHF 80.4B | CHF 777.58 | 2.35% down | 28% up | ||
| 9 | ViatrisVTRS · Health Care | CHF 31.3B | CHF 19.2B | CHF 16.74 | 1.97% down | 99% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | CHF 21.6B | CHF 111.2B | CHF 438.47 | 2.94% down | 27% up | ||
| 11 | Royalty PharmaRPRX · Health Care | CHF 16.5B | CHF 32.8B | CHF 57.03 | 1.38% down | 79% up | ||
| 12 | ZoetisZTS · Health Care | CHF 13B | CHF 27.6B | CHF 68.04 | 5.59% down | 26% down | ||
| 13 | Elanco Animal HealthELAN · Health Care | CHF 11.2B | CHF 11.1B | CHF 22.14 | 1.54% down | 26% up | ||
| 14 | United TherapeuticsUTHR · Health Care | CHF 6.6B | CHF 20.1B | CHF 470.84 | 3.16% down | 22% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | CHF 6.4B | CHF 10B | CHF 51.72 | 0.02% down | 17% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | CHF 4.2B | CHF 16.7B | CHF 124.49 | 1.06% down | 66% down | ||
| 17 | Amneal PharmaceuticalsAMRX · Health Care | CHF 3.1B | CHF 6.3B | CHF 18.01 | 2.24% down | 90% up | ||
| 18 | Ionis PharmaceuticalsIONS · Health Care | CHF 3B | CHF 3.8B | CHF 22.92 | 0.62% down | 63% down | ||
| 19 | PTC TherapeuticsPTCT · Health Care | CHF 2.4B | CHF 4.1B | CHF 49.12 | 3.16% down | 21% down | ||
| 20 | InsmedINSM · Health Care | CHF 1.9B | CHF 26.7B | CHF 121.66 | 20.58% up | 40% down | ||
| 21 | Legend BiotechLEGN · Health Care | CHF 1.5B | CHF 2.6B | CHF 13.56 | 0.92% down | 41% down | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | CHF 1.3B | CHF 4.8B | CHF 241.64 | 3.94% down | 50% up | ||
| 23 | CytokineticsCYTK · Health Care | CHF 1.2B | CHF 6B | CHF 43.34 | 0.27% up | 19% down | ||
| 24 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 1.2B | CHF 5.2B | CHF 36.76 | 1.25% up | 13% up | ||
| 25 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 1.1B | CHF 7.8B | CHF 334.11 | 0.34% down | 27% down | ||
| 26 | TG TherapeuticsTGTX · Health Care | CHF 895.4M | CHF 8.3B | CHF 54.64 | 1.88% down | 117% up | ||
| 27 | Praxis Precision MedicinesPRAX · Health Care | CHF 789.8M | CHF 7.3B | CHF 261.82 | 1.87% up | 86% up | ||
| 28 | Cogent BiosciencesCOGT · Health Care | CHF 789.6M | CHF 4.1B | CHF 23.36 | 0.25% down | 20% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | CHF 788.3M | CHF 12.8B | CHF 65.84 | 0.22% up | 21% up | ||
| 30 | Mirum PharmaceuticalsMIRM · Health Care | CHF 709.8M | CHF 5.3B | CHF 80.43 | 3.27% up | 34% up | ||
| 31 | Corcept TherapeuticsCORT · Health Care | CHF 704.6M | CHF 6B | CHF 54.72 | 4.15% down | 10% down | ||
| 32 | Belite BioBLTE · Health Care | CHF 657.3M | CHF 5.2B | CHF 127.18 | 3.33% down | 43% up | ||
| 33 | Spyre TherapeuticsSYRE · Health Care | CHF 655M | CHF 7.8B | CHF 82.22 | 3.77% down | 332% up | ||
| 34 | Summit TherapeuticsSMMT · Health Care | CHF 632.6M | CHF 7.1B | CHF 8.90 | 0.67% up | 36% down | ||
| 35 | Axsome TherapeuticsAXSM · Health Care | CHF 580.9M | CHF 6B | CHF 114.26 | 1.25% up | 6% down | ||
| 36 | Protagonist TherapeuticsPTGX · Health Care | CHF 562.7M | CHF 6.8B | CHF 104.44 | 2.47% down | 51% up | ||
| 37 | Travere TherapeuticsTVTX · Health Care | CHF 509.7M | CHF 3.9B | CHF 40.68 | 3.86% down | 45% up | ||
| 38 | Edgewise TherapeuticsEWTX · Health Care | CHF 465.4M | CHF 3.8B | CHF 34.67 | 0.48% down | 86% up | ||
| 39 | Dianthus TherapeuticsDNTH · Health Care | CHF 447.1M | CHF 4B | CHF 71.44 | 1.01% up | 108% up | ||
| 40 | Oruka TherapeuticsORKA · Health Care | CHF 411.5M | CHF 5.6B | CHF 82.17 | 1.91% up | 255% up | ||
| 41 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 404.4M | CHF 6.8B | CHF 98.36 | 1.88% down | 18% up | ||
| 42 | Definium TherapeuticsDFTX · Health Care | CHF 370.6M | CHF 3.4B | CHF 24.83 | 1.24% up | 168% up | ||
| 43 | ErascaERAS · Health Care | CHF 333.6M | CHF 4.2B | CHF 11.98 | 3.34% up | 395% up | ||
| 44 | VeradermicsMANE · Health Care | CHF 128.5M | CHF 4.4B | CHF 104.75 | 0.38% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8421 CHF).
Questions and answers
Which pharmaceutical companies in the United States rank first by total assets?
Pfizer (CHF 175.3B), Johnson & Johnson (CHF 167.8B) and Merck & Co (CHF 115.3B) are the top three of the 44 pharmaceutical companies in the United States ranked by total assets as of 20 Nov 2026, 05:22 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by total assets.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by total assets have a combined market value of CHF 3.15T as of 20 Nov 2026, 05:22 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by total assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.